Primer on Precision Medicine for Complex Chronic Disorders

被引：27
作者：
Whitcomb, David C. [1 ]
机构：
[1] Univ Pittsburgh, Dept Med Cell Biol & Mol Physiol & Human Genet, Pittsburgh, PA 15260 USA
来源：
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY | 2019年 / 10卷
关键词：
CHRONIC-PANCREATITIS; CLASSIFICATION; CONSENSUS; RECURRENT; BASKET; TRIAL;
D O I：
10.14309/ctg.0000000000000067
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Precision medicine promises patients with complex disorders the right treatment for the right patient at the right dose at the right time with expectation of better health at a lower cost. The demand for precision medicine highlights the limitations of modern Western medicine. Modern Western medicine is a population-based, top-down approach that uses pathology to define disease. Precision medicine is a bottom-up approach that identifies predisease disorders using genetics, biomarkers, and modeling to prevent disease. This primer demonstrates the contrasting strengths and limitations of each paradigm and why precision medicine will eventually deliver on the promises.
引用
收藏
页数：5
相关论文
共 31 条
  • [1] [Anonymous], 2019, HLTH EC COSTS CHRON
  • [2] Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework
    Atkinson, AJ
    Colburn, WA
    DeGruttola, VG
    DeMets, DL
    Downing, GJ
    Hoth, DF
    Oates, JA
    Peck, CC
    Schooley, RT
    Spilker, BA
    Woodcock, J
    Zeger, SL
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (03) : 89 - 95
  • [3] The flexner report and the standardization of American medical education
    Beck, AH
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (17): : 2139 - 2140
  • [4] Human-based systems: Mechanistic NASH modelling just around the corner?
    Boeckmans, Joost
    Natale, Alessandra
    Buyl, Karolien
    Rogiers, Vera
    De Kock, Joery
    Vanhaecke, Tamara
    Rodrigues, Robim M.
    [J]. PHARMACOLOGICAL RESEARCH, 2018, 134 : 257 - 267
  • [5] A GWAS meta-analysis from 5 population-based cohorts implicates ion channel genes in the pathogenesis of irritable bowel syndrome
    Bonfiglio, F.
    Henstrom, M.
    Nag, A.
    Hadizadeh, F.
    Zheng, T.
    Cenit, M. C.
    Tigchelaar, E.
    Williams, F.
    Reznichenko, A.
    Ek, W. E.
    Rivera, N. V.
    Homuth, G.
    Aghdassi, A. A.
    Kacprowski, T.
    Mannikko, M.
    Karhunen, V.
    Bujanda, L.
    Rafter, J.
    Wijmenga, C.
    Ronkainen, J.
    Hysi, P.
    Zhernakova, A.
    D'Amato, M.
    [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2018, 30 (09)
  • [6] The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
    Buzzetti, Elena
    Pinzani, Massimo
    Tsochatzis, Emmanuel A.
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2016, 65 (08): : 1038 - 1048
  • [7] An efficient basket trial design
    Cunanan, Kristen M.
    Iasonos, Alexia
    Shen, Ronglai
    Begg, Colin B.
    Gonen, Mithat
    [J]. STATISTICS IN MEDICINE, 2017, 36 (10) : 1568 - 1579
  • [8] de Souza HSP, 2016, NAT REV GASTRO HEPAT, V13, P13, DOI [10.1038/nrgastro.2016.186, 10.1038/nrgastro.2015.186]
  • [9] Chronic pancreatitis: Diagnosis, classification, and new genetic developments
    Etemad, B
    Whitcomb, DC
    [J]. GASTROENTEROLOGY, 2001, 120 (03) : 682 - 707
  • [10] Applying the Bradford Hill criteria in the 21st century: How data integration has changed causal inference in molecular epidemiology
    Fedak K.M.
    Bernal A.
    Capshaw Z.A.
    Gross S.
    [J]. Emerging Themes in Epidemiology, 12 (1):
1234